Supplements for Women's Hormonal Health
What the Evidence Actually Says

How to Read an Evidence Grade

Before reviewing specific supplements, it's worth understanding how to evaluate evidence claims. The hierarchy of evidence matters:

• Randomized controlled trials (RCTs) in humans are the gold standard. Multiple RCTs with consistent results give us high confidence.
• Observational studies can identify associations but cannot establish causation.
• Animal studies and in vitro research are hypothesis-generating — they suggest mechanisms but don't confirm human efficacy.
• Anecdote and case reports have the least evidential weight, though they can signal where formal research is warranted.

The supplements below are graded A (multiple RCTs), B (1–2 RCTs or strong observational data), or C (animal/mechanistic evidence only, limited human data).

Tier A: Strong Evidence, High Priority

Magnesium Glycinate — Grade A

Magnesium is a cofactor in over 300 enzymatic reactions, including insulin signaling, cortisol metabolism, sleep regulation, and neurotransmitter production. Deficiency is common — estimated at 45–60% of adults in the US — and is exacerbated by chronic stress, alcohol use, and high refined carbohydrate intake. Multiple RCTs support magnesium supplementation for:

• Reducing fasting insulin and improving insulin sensitivity
• Improving sleep quality (reduced waking, improved sleep architecture)
• Reducing cortisol area under the curve
• Reducing frequency of migraines (relevant for perimenopausal women who often experience increased migraine frequency)

Dose: 300–400mg magnesium glycinate at bedtime. Glycinate is the best-absorbed form for these applications and least likely to cause loose stool.

Vitamin D3 + K2 — Grade A

Vitamin D functions as a hormone, not just a vitamin — it regulates over 200 genes, including those governing immune function, insulin secretion, and mood. Deficiency (<30 ng/mL, affecting roughly 42% of US adults) is independently associated with increased cardiovascular risk, depression, insulin resistance, and osteoporosis. In perimenopausal women, vitamin D3 supplementation with K2 (which directs calcium into bone rather than arteries) has multiple RCT-level support for:

• Bone mineral density preservation
• Reduced insulin resistance (particularly at levels above 40 ng/mL)
• Mood stabilization

Dose: 2,000–5,000 IU D3 daily with 100–200mcg MK-7 K2. Test 25-OH vitamin D to establish baseline and target 50–70 ng/mL.

Omega-3 Fatty Acids (EPA/DHA) — Grade A

EPA and DHA are anti-inflammatory fatty acids with extensive RCT evidence for cardiovascular protection, mood support, and triglyceride reduction. In perimenopausal women, omega-3 supplementation has shown significant effects on reducing triglycerides (a primary marker of insulin resistance), reducing hot flash frequency in some trials, and supporting brain health. Cardiovascular risk rises after menopause — omega-3s address one of the primary drivers.

Dose: 2–3g combined EPA + DHA daily. Triglyceride reduction requires doses at the higher end (2.5–3g). Choose triglyceride-form fish oil for superior absorption over ethyl ester form.

Collagen Peptides — Grade A (for skin, joint, and bone applications)

Reviewed in detail in our collagen and longevity article. Multiple RCTs support 2.5–10g hydrolyzed collagen peptides daily for skin elasticity, joint pain, and bone mineral density in women over 40, particularly when taken with vitamin C.

Tier B: Good Evidence, Targeted Use

Myo-Inositol — Grade B

Myo-inositol is a naturally occurring carbohydrate that serves as a secondary messenger in insulin signaling. It has the strongest evidence base in women with PCOS (polycystic ovary syndrome), where multiple RCTs demonstrate improvements in insulin sensitivity, ovulation frequency, and androgen levels. Emerging evidence suggests similar benefits for perimenopausal insulin resistance. It is among the better-studied compounds for women's hormonal health specifically.

Dose: 2–4g myo-inositol daily (often combined with 200mcg chromium picolinate in trials). A 40:1 ratio of myo-inositol to D-chiro-inositol appears in several protocols.

Berberine — Grade B

Berberine activates AMPK, the same energy-sensing pathway targeted by metformin — earning it comparisons to the prescription drug in metabolic research. Multiple RCTs in type 2 diabetes and PCOS show improvements in fasting glucose, fasting insulin, and HbA1c. Evidence specifically in perimenopausal women is limited, but the mechanism is directly relevant. Berberine has significant drug interactions (including with blood thinners and some statins) and should not be used during pregnancy.

Dose: 500mg two to three times daily with meals. Cycling is often recommended (8 weeks on, 4 weeks off) due to potential effects on gut microbiome with continuous use.

Ashwagandha (KSM-66) — Grade B

The KSM-66 extract of ashwagandha (Withania somnifera) has the most robust clinical evidence within this category. Multiple RCTs demonstrate reductions in perceived stress, cortisol AUC, anxiety scores, and improvements in sleep quality. One 2019 RCT found improvements in thyroid function in subclinical hypothyroid patients. The cortisol-reducing effects are particularly relevant for perimenopausal women, where elevated cortisol drives visceral fat accumulation and worsens insulin resistance.

Dose: 300–600mg KSM-66 extract daily. Morning or evening dosing — the cortisol effects are meaningful at both.

Tier C: Promising but Insufficient Human Evidence

Diindolylmethane (DIM) — Grade C

DIM is derived from cruciferous vegetables and promotes a favorable shift in estrogen metabolism — specifically increasing the 2-hydroxy estrogen pathway relative to the 16-hydroxy pathway, a balance associated with reduced estrogen-sensitive cancer risk. The mechanism is well-characterized. Human clinical trial data is limited in scope and size. It is not a substitute for medical HRT and should not be positioned as one.

Phosphatidylserine — Grade C

Phosphatidylserine is a phospholipid that supports cortisol regulation and cognitive function. Small studies suggest it may blunt the cortisol response to acute stress. Evidence for perimenopausal-specific applications is limited but mechanistically plausible.

How to Build Your Protocol

Start with deficiencies, not additions. Before adding any supplement, identify what you're actually deficient in or what specific mechanism you're targeting. The sequencing matters:

1. Foundation: Magnesium glycinate, vitamin D3/K2, omega-3 fatty acids. These address the most common deficiencies in perimenopausal women and have the broadest benefit.
2. Metabolic layer: Add myo-inositol and/or berberine if fasting insulin or HOMA-IR is elevated (per your labs — see our biomarker guide).
3. Cortisol layer: Add ashwagandha if stress, disrupted sleep, or elevated cortisol on DUTCH testing is a primary concern.
4. Structural layer: Add collagen peptides for skin, joint, and bone support — especially if post-menopausal or within 5 years of menopause.

Track your response over 8–12 weeks using the labs outlined in our biomarker article. Adjust based on data, not on how you imagine things are going.